Location & dates EMBL Heidelberg, Germany 3 - 5 Nov 2013
Deadlines Registration closed Abstract submission closed

Latest News

  • Pre-conference workshop will be hosted by Illumina prior to the conference
    on 3 November from 11.30 - 12.30.
  • Please contact Tim Nürnberger for Late Registration to the conference.

  • Final Programme and poster listings are now available online.

  • Updated Conference Bus Schedule is now available online.

Why attend

  • Topics
    • Cancer Genetics
    • Functional Genomics & Epigenomics of Cancer
    • Systems Biology & Integrated Analyses of Cancer
    • Cancer Model Systems & Systems Pharmacology
    • Translation & Clinical Impact of Cancer Genomics
  • Summary
    This conference will provide an opportunity to learn about, and keep up-to-date with, the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer mouse models, and the translation and clinical impact of scientific results obtained. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.

    European Cancer Genomics research is particularly strong in the Heidelberg area, with three International Cancer Genome Consortium (www.icgc.org) projects being currently pursued with significant participation from Heidelberg institutions, including EMBL. As in our 2011 meeting, a large number of renowned speakers will be invited, with a strong representation of overseas speakers. The atmosphere at the conference will make this an exceptional event with cutting edge science, extensive scientific discussions, and ample possibilities for meetings between and after sessions, to facilitate in-depth discussions and new collaborations.

EMBL ATC Corporate Partnership Programme